HomeWeight LossSEMAGLUTIDE ODT 10MG (TABLET)SEMAGLUTIDE/B12 0.6 MG/ 500 MCG/ML (2 ML)Oral Tirzepatide 5mgTirzepatide + B12 Injection 5mg/0.5mg/mLHair RegrowthFinasteride 1mg TabletsFinasteride + Minoxidil 0.1%/5% Topical Solution (PER ML)Minoxidil 2%Finasteride + Minoxidil 0.1%/5% (Foam)Sexual HealthTadalafil 10mg TabletsTadalafil 20mg TabletsSildenafil 50mg Sublingual TabletsSildenafil 50mg–100mg CapsulesSkin CareHyaluronic Acid + Niacinamide + Tretinoin 0.5%/4%/0.025%Finasteride + Minoxidil + Tretinoin 0.25%/5%/0.03%Wellness & PeptidesNAD+ 300mg/mL Nasal SpraySermorelin 3mg/mLGlutathione 200mg/mLLipo-B B12/MICNAD+ 100mg/mLSuppliesM8TRIX 29G 1mL Subcutaneous Syringe PackInsulin Syringes with NeedlesSterile Alcohol Prep PadsProvidersServicesAboutFAQsBlogJoin as Provider
HAIR LOSS TREATMENT

Finasteride + Minoxidil 0.1%/5% Topical Solution

  • A topical finasteride and minoxidil formulation available as a provider-guided hair-loss treatment option.
  • Treatment requires review by a licensed healthcare provider and a prescription when clinically appropriate.
Get Started →

This topical formulation contains finasteride 0.1% and minoxidil 5%. Finasteride affects the conversion of testosterone to dihydrotestosterone (DHT), while topical minoxidil is used for certain types of hair loss. Your provider determines whether this specific formulation is appropriate for you.

Apply the medication exactly as prescribed and follow the instructions provided with your medication. Because this combination formulation contains topical finasteride, follow the specific application, amount, frequency, and handling instructions provided by your healthcare provider and dispensing pharmacy.

Topical finasteride can be absorbed through the skin and may cause systemic or local adverse effects. FDA has reported adverse events associated with compounded topical finasteride, including sexual, mood-related, and local skin reactions, and notes a risk of inadvertent transfer to others.

Your healthcare provider determines whether this treatment is appropriate for you and can review your health history, medications, potential risks, and treatment response as part of your ongoing care.

Finasteride + Minoxidil 0.1%/5% Topical Solution
HOW IT WORKS

Start Your Hair Loss
Care Journey

A simple provider-guided process to determine whether this topical treatment may be appropriate for your hair-loss needs.

  1. 1
    Get Started

    Provide the information needed for a licensed healthcare provider to understand your hair-loss concerns and treatment needs.

    Start online

  2. 2
    Provider Review

    A licensed healthcare provider reviews your information and determines whether this topical treatment is clinically appropriate for you.

    Prescription required

  3. 3
    Start Your Treatment

    If prescribed, receive instructions for applying your treatment and follow the care plan provided by your healthcare provider.

    Provider-guided care

TOPICAL HAIR LOSS CARE DETAILS

Important Things to Know
Before Starting Treatment

Review important considerations about application, skin exposure, safety, treatment expectations, and ongoing provider guidance.

  • Understanding the Two Active Ingredients
  • Application and Handling Instructions
  • Skin Reactions and Local Effects
  • Avoiding Unintended Transfer
  • Systemic Finasteride Exposure
  • Monitoring Your Treatment Response

This formulation contains topical finasteride. FDA states that there are currently no FDA-approved topical finasteride products, and compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing. Discuss the potential risks and benefits with your healthcare provider before starting treatment.

OTHER HAIR LOSS OPTIONS

Explore More
Treatment Options

Explore other hair-loss treatment options available through provider-guided care and review which approach may be appropriate for your needs.

YOUR TREATMENT JOURNEY

Your Topical Hair Loss
Care Plan

Your provider determines the appropriate treatment approach and may review your response over time to guide your ongoing care.

If prescribed, your provider will give you specific instructions for applying the topical treatment and handling the medication safely.

Use the medication according to your prescription and follow the application, storage, and handling instructions provided.

Your provider may review your treatment experience, skin tolerance, and hair-loss concerns to determine the appropriate next step in your care.

Treatment instructions and ongoing care vary by patient and formulation. Do not change the amount, frequency, or application method without guidance from your healthcare provider.

Frequently Asked Questions

It is a topical formulation containing finasteride 0.1% and minoxidil 5% that may be prescribed as part of provider-guided hair-loss care. Your healthcare provider determines whether this specific formulation is appropriate for you.

Finasteride reduces the conversion of testosterone to dihydrotestosterone (DHT), while topical minoxidil is used to help treat certain types of hair loss. These ingredients have different mechanisms, and your provider can determine whether this combination is appropriate for your individual circumstances. U.S. Food and Drug Administration

This specific topical finasteride and minoxidil combination is not an FDA-approved product. FDA states that there are currently no FDA-approved topical formulations of finasteride, including topical finasteride combined with other active ingredients. Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.

FDA has received reports of systemic adverse events associated with compounded topical finasteride, including sexual and mood-related effects, as well as local reactions such as irritation, redness, dryness, scaling, stinging, and burning. Topical finasteride can also be unintentionally transferred to other people through contact with the treated area.

Hair-loss treatment does not produce immediate changes, and response varies among individuals. Minoxidil may take several months of consistent use before results can be evaluated, while treatment with finasteride-containing formulations also requires ongoing use and provider guidance.

This product contains topical finasteride. Treatment requires evaluation and a prescription from a licensed healthcare provider. The FDA has identified potential risks associated with compounded topical finasteride, and patients should discuss the potential benefits, risks, and appropriate handling of the formulation with their provider.